Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 352,183 |
|
|||||
| News | - | ||||||
| Day High | 2.21 | Low High |
|||||
| Day Low | 2.11 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lyell Immunopharma Inc | LYEL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.03 | -1.36% | 2.17 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.19 | 2.11 | 2.21 | 2.17 | 2.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,707 | 352,183 | $ 2.16 | $ 760,763 | - | 1.32 - 3.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:30:32 | 1 | $ 2.19 | USD |
Lyell Immunopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 548.85M | 254.10M | - | 2.92M | -234.63M | -0.92 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lyell Immunopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LYEL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.31 | 2.55 | 2.11 | 2.32 | 805,923 | -0.14 | -6.06% |
| 1 Month | 2.27 | 3.145 | 2.015 | 2.44 | 987,727 | -0.10 | -4.41% |
| 3 Months | 1.82 | 3.2556 | 1.69 | 2.30 | 919,748 | 0.35 | 19.23% |
| 6 Months | 1.58 | 3.2556 | 1.52 | 2.10 | 1,128,074 | 0.59 | 37.34% |
| 1 Year | 1.91 | 3.97 | 1.32 | 2.31 | 1,021,356 | 0.26 | 13.61% |
| 3 Years | 18.75 | 19.84 | 1.32 | 4.81 | 941,057 | -16.58 | -88.43% |
| 5 Years | 18.75 | 19.84 | 1.32 | 4.81 | 941,057 | -16.58 | -88.43% |
Lyell Immunopharma Description
| Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors). |
